LDL receptor activity is down-regulated similarly by a cholesterol-containing diet high in palmitic acid or high in lauric and myristic acids in cynomolgus monkeys.
To determine the mechanisms whereby diets differing widely in fatty acid composition affect plasma LDL cholesterol and apolipoprotein B concentrations, LDL kinetics and receptor- and nonreceptor-mediated LDL catabolism were investigated in 27 cynomolgus monkeys fed diets containing 0.05 mg cholesterol/kJ and 40% fat energy as corn oil alone (unsaturated fat diet rich in oleic and linoleic acids), nonhydrogenated coconut oil alone (saturated fat diet, rich in lauric and myristic acids) or an oil blend (rich in palmitic acid). Consumption of the oil blend and saturated fat diets significantly elevated total cholesterol, LDL cholesterol and apolipoprotein B concentrations relative to the unsaturated fat diet and the saturated fat diet significantly increased plasma total cholesterol and LDL cholesterol compared with the oil blend diet. However, despite the greater increases in plasma total cholesterol, LDL cholesterol and apolipoprotein B in the saturated fat vs. the oil blend dietary group, the receptor-mediated LDL fractional catabolic rate was comparable in the oil blend and saturated fat diet groups. In addition, consumption of the oil blend or saturated fat diet increased the production rate of LDL apolipoprotein B and nonreceptor-mediated LDL apolipoprotein B transport (disposal) relative to the unsaturated fat diet. Our data, therefore, suggest that consumption of the oil blend or saturated fat diet elevated plasma total cholesterol and LDL cholesterol relative to the unsaturated fat diet, and the oil blend diet abundant in palmitic acid seems to have down-regulated the LDL receptor as much as a more saturated fat diet abundant in lauric and myristic acids.
Stucchi
A F
AF
Department of Clinical Sciences, University of Massachusetts-Lowell 01854, USA.
Terpstra
A H
AH
Nicolosi
R J
RJ
D000818:Animals; D001055:Apolipoproteins B / Q000378:metabolism; D002784:Cholesterol / Q000097:blood; D002791:Cholesterol, Dietary / Q000494:pharmacology*; D004032:Diet; D015536:Down-Regulation / Q000187:drug effects*; D007850:Lauric Acids / Q000008:administration & dosage / Q000494:pharmacology*; D008074:Lipoproteins / Q000097:blood; D008252:Macaca fascicularis; D008297:Male; D009227:Myristic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D010169:Palmitic Acids / Q000008:administration & dosage / Q000494:pharmacology*; D011973:Receptors, LDL / Q000187:drug effects* / Q000378:metabolism
D001055:Apolipoproteins B; D002791:Cholesterol, Dietary; D007850:Lauric Acids; D008074:Lipoproteins; D009227:Myristic Acids; D010169:Palmitic Acids; D011973:Receptors, LDL; D002784:Cholesterol